Data is not available at this time.
Kewpie Corporation is a leading Japanese food manufacturer specializing in condiments, egg products, and processed foods, with a strong presence in both domestic and international markets. The company’s core revenue model is driven by its diversified product portfolio, including mayonnaise, dressings, liquid eggs, and packaged salads, catering to retail, foodservice, and industrial clients. Kewpie’s vertically integrated operations—spanning production, logistics, and warehousing—enhance cost efficiency and supply chain resilience. Operating in the competitive packaged foods sector, Kewpie differentiates itself through brand loyalty, product innovation, and a focus on health-conscious offerings like baby foods and nursing care products. Its market position is reinforced by strategic partnerships and a robust distribution network, particularly in Asia. The company’s fine chemical segment, featuring hyaluronic acid, adds a high-margin niche to its business. Kewpie’s ability to adapt to shifting consumer preferences, such as demand for convenience and functional foods, underscores its resilience in the consumer defensive sector.
Kewpie reported revenue of JPY 483.99 billion for FY2024, with net income of JPY 21.42 billion, reflecting a net margin of approximately 4.4%. Operating cash flow stood at JPY 63.13 billion, indicating solid cash generation. Capital expenditures of JPY 18.12 billion suggest ongoing investments in production capacity and innovation, though free cash flow remains healthy. The company’s efficiency is supported by its integrated supply chain and economies of scale.
Diluted EPS of JPY 154.09 highlights Kewpie’s earnings power, driven by stable demand for staple food products and margin management. The company’s capital efficiency is evident in its ability to maintain profitability despite inflationary pressures, with a focus on premium and functional food segments contributing to higher-margin growth.
Kewpie’s balance sheet is robust, with JPY 78.14 billion in cash and equivalents and modest total debt of JPY 21.56 billion, resulting in a conservative leverage profile. The company’s liquidity position supports its dividend policy and strategic investments, while its asset-light logistics model minimizes fixed-cost burdens.
Kewpie’s growth is underpinned by product innovation and expansion into health-focused categories, such as nursing care foods. The company pays a dividend of JPY 54 per share, reflecting a payout ratio aligned with its stable cash flows. While organic growth is steady, international expansion and acquisitions could provide incremental upside.
With a market cap of JPY 448.14 billion, Kewpie trades at a P/E ratio of approximately 21x, in line with peers in the consumer defensive sector. The negative beta (-0.028) suggests low correlation to broader market volatility, appealing to risk-averse investors. Market expectations likely hinge on margin improvement and overseas growth.
Kewpie’s strategic advantages include its strong brand equity, diversified product mix, and operational integration. The outlook remains stable, supported by demand for essential food products and potential growth in functional and convenience foods. Challenges include cost pressures and competitive intensity, but the company’s focus on R&D and efficiency initiatives positions it well for long-term resilience.
Company filings, Bloomberg
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |